Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO save search
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published: 2024-01-04 (Crawled : 11:00) - globenewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 92.31%
H: 20.0%
C: 1.24%
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 1.44%
H: 3.68%
C: 2.4%
treatment research therapeutics
Bactolife Raises EUR 30 million in Series A Financing
Published: 2023-08-08 (Crawled : 06:00) - prnewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 15.34%
H: 3.26%
C: 1.64%
Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial
Published: 2023-08-08 (Crawled : 10:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 15.34%
H: 3.26%
C: 1.64%
obesity risk trial cardiovascular
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
Published: 2023-06-06 (Crawled : 13:20) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 2.4%
H: 0.25%
C: -0.54%
MC | $54.6 2.59% 0.0% 610K
|
Finance
|
| O: -1.08%
H: 5.06%
C: 3.17%
PRTK | $2.23 0.0% 4.8M
|
Health Technology
|
| O: 12.76%
H: 2.26%
C: -1.81%
pharmaceuticals acquired
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
Published: 2024-02-05 (Crawled : 11:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 2.37%
H: 1.9%
C: 1.61%
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
|
| O: 8.81%
H: 1.5%
C: 0.86%
acquire
Novo Holdings to Acquire Catalent
Published: 2024-02-05 (Crawled : 12:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 2.37%
H: 1.9%
C: 1.61%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.79%
H: 0.0%
C: -0.8%
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
|
| O: 8.81%
H: 1.5%
C: 0.86%
acquire
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
Published: 2021-07-12 (Crawled : 12:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 1.22%
H: 0.4%
C: -0.24%
PRTA 4 | $20.565 -3.41% -3.53% 440K
|
Health Technology
|
| O: 8.06%
H: 0.28%
C: -11.2%
acquisition
Highlights to be presented at Novo Nordisk’s Capital Markets Day 2024
Published: 2024-03-07 (Crawled : 07:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 6.97%
H: 3.63%
C: 1.86%
day
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published: 2023-06-28 (Crawled : 02:00) - prnewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: -0.94%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -2.09%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 6.1%
H: 5.34%
C: 0.82%
disease japan kidney market
Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022
Published: 2022-04-29 (Crawled : 07:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 5.98%
H: 1.44%
C: -0.42%
sales
Novo Holdings acquires KabaFusion
Published: 2022-11-02 (Crawled : 12:20) - prnewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 4.84%
H: 4.18%
C: 1.48%
Novo Nordisk's sales increased by 26% in Danish kroner and by 16% at constant exchange rates to DKK 128.9 billion in the first nine months of 2022
Published: 2022-11-02 (Crawled : 07:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 4.84%
H: 4.18%
C: 1.48%
sales
Novo Nordisk's sales increased by 11% in Danish kroner and by 14% at constant exchange rates to DKK 140.8 billion in 2021
Published: 2022-02-02 (Crawled : 07:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 4.81%
H: 0.0%
C: 0.0%
sales one
Novo Nordisk A/S – Share repurchase programme
Published: 2022-08-22 (Crawled : 13:20) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.78%
H: 0.49%
C: -0.88%
repurchase
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Published: 2022-08-22 (Crawled : 12:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.78%
H: 0.49%
C: -0.88%
trial diabetes phase 2
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis
Published: 2023-10-10 (Crawled : 21:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.75%
H: 2.82%
C: 2.42%
kidney
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
Published: 2023-11-02 (Crawled : 07:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.69%
H: 0.96%
C: -0.35%
sales
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
license therapeutics agreement
MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance Pipeline of Central Nervous System Therapeutics
Published: 2023-10-30 (Crawled : 18:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.44%
H: 0.71%
C: -0.33%
pipeline series system therapeutics funding
Novo Nordisk A/S – Share repurchase programme
Published: 2022-11-14 (Crawled : 16:00) - globenewswire.com
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 3.13%
H: 0.56%
C: -0.46%
repurchase
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.